Ionetix Corp / DE /

Ionetix Corp is a Delaware-incorporated company operating in the nuclear medicine and radiopharmaceutical sector, focused on compact cyclotron systems used to produce fluorine-18 and other short-lived medical isotopes for PET imaging. The company filed an 8-K with the SEC on May 26, 2026 (accession 0001213900-26-060830), reflecting a material corporate development reportable under Exchange Act requirements. The company reached its current public status through a blank-check vehicle transaction and continues to operate at the intersection of medical device manufacturing and radiopharmaceutical production. Full filing history, deal structure details, and ongoing corporate disclosures for Ionetix Corp are available to subscribers at SpacDesk — sign up today for comprehensive SPAC and post-merger company data.